Nexavar may help breast cancer drugs work longer
Reuters - Fri Dec 11, 9:01 pm ETU.S. researchers may have found a way to overcome resistance to hormone-blocking breast cancer drugs, extending the life of treatments that keep the disease in check.
2928 Stories, most recent news story added 26 minutes ago
U.S. researchers may have found a way to overcome resistance to hormone-blocking breast cancer drugs, extending the life of treatments that keep the disease in check.
New results from a landmark women's health study raise the exciting possibility that bone-building drugs such as Fosamax and Actonel may help prevent breast cancer.
Magnetic resonance imaging (MRI) coupled with mammography detects almost all cancers at an early stage, thereby reducing the incidence of advanced stage breast cancer in high-risk women.
Magnetic resonance imaging (MRI) coupled with mammography detects almost all cancers at an early stage, thereby reducing the incidence of advanced stage breast cancer in high-risk women."Earlier stage breast cancers are more likely to be curable," said lead researcher Ellen Warner, M.D., M.Sc., medical oncologist in the Department of Medicine, Division of Medical Oncology at Sunnybrook Health ...
New results from a landmark women's health study raise the exciting possibility that bone-building drugs such as Fosamax and Actonel may help prevent breast cancer. New results from a landmark women's health study raise the exciting possibility that bone-building drugs such as Fosamax and Actonel may help prevent breast cancer. Women who already were using these medicines when the study began ...
Lapatinib plus trastuzumab are significantly better than lapatinib alone in extending the lives of breast cancer patients whose tumors are HER2-positive, according to new research.
New results from a landmark women's health study raise the exciting possibility that bone-building drugs such as Fosamax and Actonel might help prevent breast cancer.Women who already were using these medicines when the study began were about one-third less likely to develop invasive breast cancer over the next seven years than women not taking such pills, doctors reported Thursday.The study is ...
The Hagerstown Trust Division of The Columbia Bank recently donated $466.39 to Breast Cancer Awareness-Cumberland Valley (BCA-CV).
THURSDAY, Dec. 10 (HealthDay News) -- Adding chemotherapy to standard cancer-suppressing tamoxifen can boost survival in postmenopausal women with the most common type of breast cancer, known as estrogen receptor-positive, and it's best given before the tamoxifen regimen starts, according to a new study.
Circulating metastatic breast cancer cells can lose their epithelial receptors, a process that enables them to travel through the bloodstream undetected, according to research from The University of Texas M. D. Anderson Cancer Center.
ASSOCIATED PRESS SAN ANTONIO — Women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other treatments, doctors reported Friday. The study is the first big test of combining Herceptin and Tykerb. In the study of 300 patients, women receiving both ...